Seda Türkoğlu Babakurban, MD, PhD, is full Associate Professor in the Departmet of Otorhinolaryngology-Head and Neck Surgery of Baskent University of Medical Faculty, Turkey. She is also an academic member of the Department of Medical Genetics of Baskent University of Medical Faculty, Turkey. She received her MD degree at the University of Hacettepe, Turkey in 2003 and completed her residency programme in OHNS Department of Baskent University Medical Faculty in 2009. She became Professor in 2023. She received her PhD degree in Medical Biology in 2018. Her clinical and research activities are especially focused on head and oncology and tumor biology.  She is an active member of Turkish Head and Neck Society and European Head and Neck Society. She authored or co-authored in 50 international/national journal papers.

Dr Hackman serves as a Distinguished Professor of Head and Neck Surgery at the University of North Carolina and Vice Chair of Inpatient Operations and Quality, as well as Chair of the Patient Care Section for the American Head and Neck Society, and member of the Executive Committee for the Salivary Gland Section of AHNS. He has over 15 years of experience with risk adaptive neoadjuvant therapy prior to surgery for mucosal head and neck cancer, and also pioneers the largest volume in-office sialendoscopy practice in the US.

Dr. Markus Blaurock is a board-certified Otorhinolaryngologist, Head- and Neck Surgeon. He attended medical school and residency at the University of Greifswald with some clinical training at the Carver College of Medicine in Iowa City, Iowa in the USA. After board certification in 2018 he attended the IFHNOS global online fellowship in head and neck surgery with an observership at MD Anderson Cancer Center, USA, graduating in 2020. Currently he continues work at the University of Greifswald as a head and neck surgeon, including robotic surgery, and teaches medical and dentristry students. 

His research focus is on process quality in head and neck cancer. This includes the detection of sleep apnea, prehabilitation and antibiotic use as well as followup-quality. Additionally, he has been an active participant in clinical trials including phase II and III pharmaceutical trials. Since 2022 he has been active in the EORTC head and neck group and was voted the chairman of the young and early career investigator group in 2024.